| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 08/25/2004 | EP1448180A1 Para-amino benzoic acids as integrin antagonists |
| 08/25/2004 | CN1524075A Substitued arylketones |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1163478C Novel process for synthesizing diethylbarbituric acid by using sodium methoxide as catalyst |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163476C Biuret polyisocyanic acid ester and its producing process |
| 08/25/2004 | CN1163144C New benzoylphenylurea insecticides and methods of using certain benzoylphenylureas to control cockroaches, ants, fleas, and termites |
| 08/24/2004 | US6780858 Hydroxyamidines and related compounds |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004056763A3 Novel glucagon antagonists |
| 08/19/2004 | WO2004046090A3 Aryl ureido derivatives and their medical use |
| 08/19/2004 | US20040162352 2-{6-[1-Ethyl-3-(4-trifluoromethoxyphenyl)ureido]-5,6,7,8-tetrahydronaphthalen-2-ylsulfanyl}-2-methylpropionic acid or other derivatives of tetralins and indanes; PPAR alpha modulators to treat or inhibit the progression of diabetes |
| 08/17/2004 | US6777561 Compounds |
| 08/17/2004 | CA2254658C New naphtalene compounds, their method of preparation and pharmaceutical compositions containing these compounds |
| 08/12/2004 | WO2004067522A1 Azaphenylalanine derivatives and their use as antithrombotic agents |
| 08/12/2004 | WO2004067500A1 Novel o-isopropylisourea salts and process for the production thereof |
| 08/12/2004 | WO2004067499A1 Fluorinated urethane compound and use thereof |
| 08/12/2004 | WO2004046162A3 Non-steroidal fxr agonists |
| 08/12/2004 | US20040157922 Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments |
| 08/12/2004 | US20040157865 exhibit activity in animal models of hyperalgesia and colitis, and are useful for the treatment and prevention of pain conditions in humans including arthritis, and for the treatment of irritable-bowel syndrome |
| 08/12/2004 | US20040157806 4-Dedimethylamino tetracycline compounds |
| 08/12/2004 | DE10302452A1 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use |
| 08/11/2004 | EP0760657B9 Novel potent inducers of terminal differentiation and methods of use thereof |
| 08/10/2004 | US6774207 Polyaspartate resins with good hardness and flexibility |
| 08/05/2004 | WO2004065356A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof |
| 08/05/2004 | WO2004065351A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 08/05/2004 | WO2004064730A2 Compounds, compositions and methods |
| 08/05/2004 | US20040152750 Hypoglycemic agents; antidiabetic agents; antilipemic agents; dietetics |
| 08/05/2004 | US20040152742 Metabolism diosrders; eating disorders; obesity; antidiabetic agents; incontinence; melanin concentrating hormone |
| 08/05/2004 | US20040152741 Arylglycine derivatives and their use as glycine transport inhibitors |
| 08/05/2004 | US20040152703 Controlling fertility; contraceptiives |
| 08/05/2004 | CA2513349A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 08/05/2004 | CA2513286A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof |
| 08/04/2004 | EP1442018A1 Novel anticancer compounds |
| 08/04/2004 | CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160321C Prepn of biurea |
| 08/03/2004 | US6770771 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals |
| 07/29/2004 | WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents |
| 07/29/2004 | WO2004063147A1 Salts and solvates of glucagon antagonists |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004046091A3 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/29/2004 | WO2004033422A3 Modulation of anxiety through blockade of anandamide hydrolysis |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/28/2004 | EP1137632B1 Thiourea inhibitors of herpes viruses |
| 07/28/2004 | CN1515638A Method for preparing coating material by using composite based on isocyanic ester |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | US20040143141 Process for production of dimers of aromatic monohydroxyl compounds |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142436 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 07/21/2004 | CN1158252C Process for preparing biurea |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/20/2004 | US6765021 Antidiabetic agents |
| 07/15/2004 | WO2004058747A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | WO2004058690A1 Developing constituents for dyeing keratin fibres |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058683A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | WO2004058164A2 Asthma and allergic inflammation modulators |
| 07/15/2004 | WO2004058145A2 Substituted amides |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | US20040138270 Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives |
| 07/15/2004 | CA2511356A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | CA2510785A1 Substituted amides |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/08/2004 | WO2004056763A2 Novel glucagon antagonists |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759549 Method of preparing amino carboxylic acids |
| 07/01/2004 | US20040127608 with at least one anchoring group and at least one matrix-compatible moiety; pigment dispersants in inks, wetting agents in coating compositions, and transfer resins in pigment processing operations |
| 07/01/2004 | US20040127574 Aminoethanol derivatives |
| 07/01/2004 | US20040127560 compounds with high binding affinity for the glucagon receptor, such as: 3-{4-[1-(4-cyclohexylphenyl)-3-(3-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid; antidiabetic agents; antiobesity agent; antihypertensive agent |
| 07/01/2004 | US20040127555 bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; treatment of A beta , IAPP, other amyloids, and alpha -synuclein or NAC fibrillogenesis |
| 07/01/2004 | US20040127518 For therapy of anxiety or pain, and other neurological, sleep, or psychological disorders, for inducing sleep, for treating glaucoma, and controlling appetite or appetive disorders |
| 07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |
| 07/01/2004 | DE10260836A1 Neue Entwicklerkomponenten New developer components |
| 06/30/2004 | EP1432677A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 06/30/2004 | CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/29/2004 | US6756378 VLA-4 inhibitor compounds |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052846A1 Tetrahydro-naphthalene derivatives |
| 06/24/2004 | WO2004052845A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 06/24/2004 | WO2004052840A1 Compounds which modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/24/2004 | WO2004052838A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122089 Analogs of andandamide and arvanil have been found to act at receptors; are useful in pain management, used as anti-proliferative/anti-tumor agents, vasodilators, and in other applications |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders |
| 06/24/2004 | CA2507137A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |